Bullous pemphigoid associated with squamous cell lung carcinoma showing remarkable response to carboplatin-based chemotherapy: a case report
- PMID: 35513831
- PMCID: PMC9074342
- DOI: 10.1186/s13256-022-03323-9
Bullous pemphigoid associated with squamous cell lung carcinoma showing remarkable response to carboplatin-based chemotherapy: a case report
Abstract
Background: Bullous pemphigoid is an uncommon dermatologic manifestation seen in squamous cell lung cancer, and evidence guiding optimal treatment, especially in the elderly population, is limited. We report herein a case of squamous cell lung cancer diagnosed after being investigated for refractory bullous pemphigoid showing marked response to carboplatin-based chemotherapy. This is the first case report that shows carboplatin can be used as an effective alternative in treatment of malignancy-associated bullous pemphigoid.
Case report: An 80-year-old caucasian man developed extensive vesiculobullous rashes on his trunk, chest, abdomen, and inguinal region associated with significant pruritus causing sleep disturbance. The diagnosis of bullous pemphigoid was confirmed on skin biopsy. The skin lesions continued to worsen even after use of oral and topical steroid in addition to oral doxycycline. Chest computed tomography revealed a spiculated left lung lesion along with mediastinal lymphadenopathy. Fine-needle aspiration from the mediastinal lymph node confirmed metastatic squamous cell lung carcinoma. Carboplatin with gemcitabine was initiated, and significant response was seen within 3 days of chemotherapy. The skin lesions continued to remain in remission even after stopping the chemotherapy.
Conclusion: Although there are still controversies regarding paraneoplastic etiology of bullous pemphigoid, this case presents a temporal association. It is the first case report showing a remarkable response with the use of a carboplatin-based regimen.
Keywords: Bullous pemphigoid; Carboplatin; Chemotherapy; Squamous cell lung carcinoma.
© 2022. The Author(s).
Conflict of interest statement
No financial or nonfinancial competing interests from any of the authors.
Figures





Similar articles
-
A case of paraneoplastic bullous pemphigoid in association with squamous cell carcinoma of lung.J Postgrad Med. 2015 Jul-Sep;61(3):197-9. doi: 10.4103/0022-3859.150906. J Postgrad Med. 2015. PMID: 26119440 Free PMC article.
-
[A case of lung cancer with bullous pemphigoid].Gan No Rinsho. 1986 May;32(5):529-33. Gan No Rinsho. 1986. PMID: 3522956 Japanese.
-
[A case of resected lung cancer associated with bullous pemphigoid].Nihon Kyobu Geka Gakkai Zasshi. 1996 Apr;44(4):524-8. Nihon Kyobu Geka Gakkai Zasshi. 1996. PMID: 8666873 Review. Japanese.
-
Bullous pemphigoid in elderly woman affected by non-small cell lung cancer treated with pembrolizumab: A case report and review of literature.J Oncol Pharm Pract. 2021 Apr;27(3):727-733. doi: 10.1177/1078155220946370. Epub 2020 Aug 9. J Oncol Pharm Pract. 2021. PMID: 32772795 Review.
-
A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy.Front Immunol. 2023 Jan 4;13:1068978. doi: 10.3389/fimmu.2022.1068978. eCollection 2022. Front Immunol. 2023. PMID: 36685586 Free PMC article.
Cited by
-
Resolution of Bullous Pemphigoid Following Lung Cancer Resection: A Case of Paraneoplastic Pemphigoid.Cureus. 2024 Nov 11;16(11):e73485. doi: 10.7759/cureus.73485. eCollection 2024 Nov. Cureus. 2024. PMID: 39669836 Free PMC article.
-
Prevalence, Spectrum and Clinical Implications of Malignancies in Patients with Bullous Pemphigoid.Acta Derm Venereol. 2023 Mar 14;103:adv00888. doi: 10.2340/actadv.v103.3979. Acta Derm Venereol. 2023. PMID: 36916952 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical